Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals | COVID-19 Impact Analysis

Global Ostomy Drainage Bags Market $4.1 Billion by 2027

The global market for ostomy drainage bags to reach nearly $4.1 billion by 2027, steadily growing at a CAGR of 4.7% over the forecast period, driven by increasing number of ostomy surgeries, due to aging population and physical disabilities.

  • Other factors driving market growth include increasing incidence of chronic conditions such as colorectal cancer, bladder cancer, Crohn’s disease, ulcerative colitis and inflammatory bowel diseases, relatively relaxed FDA approval norms for new product approvals, and rising patient awareness about availability of various products in the market.
Global Ostomy Drainage Bags Market

Ostomy surgery procedure allows bodily waste to pass through a surgically created stoma on the abdomen into a prosthetic known as a ‘pouch’ or ‘ostomy bag’ on the outside of the body or an internal surgically created pouch for continent diversion surgeries.

  • An ostomy may be necessary due to birth defects, cancer, inflammatory bowel disease, diverticulitis, incontinence and many other medical conditions. They are also necessary in cases of severe abdominal or pelvic trauma resulting from accidents or injuries. 
    • Ostomy drainage bag is a prosthetic medical device used for the collection of waste excreted from the body after an ostomy procedure, a surgical procedure performed for diverting wastage from biological system (colon, ileum, bladder) into the manually created stoma in abdomen.
Ostomy Drainage Bags Market

The prevalence of people with ostomy surgery of 0.12% of the population. The most common ostomy type is colostomy (0.07%), followed by ileostomy (0.04%) and urostomy (0.02%). 

  • The majority of ostomies are permanent (56%) versus temporary or reversible (44%). However ileostomies are more prevalent among younger people.
    • Approximately 600,000 patients undergo colorectal surgery annually in the United States, with an estimated 120,000 patients needing ileostomy creation.
      • There are well over three-quarters of a million people living in the United States with an ostomy, whereas it is estimated that approximately 13,000 ostomy surgeries are performed annually in Canada. 
        • Currently available estimates of the number of patients vary. The United Ostomy Association estimates that slightly more than 500,000 Americans have some type of stoma.

According to Eucomed, ostomy construction is a widespread technique in every surgical department worldwide with a prevalence of up to 700,000 citizens in Europe undergoing ostomy surgery. 

  • The majority of ostomies are permanent, requiring both care and consistent follow up to minimize complications, hospital readmission and unnecessary death.
    • Because ostomy surgeries are not, generally, high profile procedures among payers, there is an absence of publicly reported data on ostomy patient characteristics as well as the number and types of ostomy surgeries performed across Europe.
  • There appears to be a higher prevalence of people with an ostomy in northern European countries (United Kingdom, Ireland, Sweden, Denmark, France, Netherlands and Hungary) than the rest of Europe.
    • Overall, the ostomy population in Europe is a small, yet important subset of the patient community with long term, on-going medical needs that extend long after surgery and discharge from hospital. 
      • The ostomy manufacturers in Europe include Coloplast, ConvaTec and Hollister.

Barriers to accessibility of innovative ostomy products include:

  • Generic payment classification systems – one size fits all – a bag is a bag
  • Lack of recognition of both the medical (skin barrier) and the prosthetic (pouch) nature of ostomy devices
  • Discouragement of innovation with closed reimbursement systems, capped monthly payments and evidence requirements inappropriate for prosthetic medical devices
  • Need for increased support services – lack of standardization of ostomy nurse training programmes

The global ostomy drainage bags market report provides market size ($million 2017 to 2027), market share, growth trends, and forecast (CAGR%, 2021 to 2027). 

The global market for ostomy drainage bags segmented by product (colostomy bags, ileostomy bags, urostomy bags, continent ileostomy bags, continent urostomy bags); usage type (single-use ostomy drainage bags, multi-use drainage bags); clinical application (colorectal cancer, bladder cancer, colonic diverticulitis, inflammatory bowel disease, other diseases as crohn’s disease, ulcerative colitis); sales channel (hospitals, community), and geography.

  • Based on products, the colostomy bags segment accounted for the major revenue share of the total market, owing to high prevalence of colorectal cancer and rising awareness about the availability of different purchase options for colostomy bags.
    • However, the continent ileostomy bags segment anticipated to witness fastest growth rate during the forecast period, due to introduction of new and advanced feature products and increasing demand for continent ileostomy procedures.
  • Ostomy procedures are performed for treating urinary and fecal incontinence associated with diseases such as inflammatory bowel diseases (IBD), colorectal cancer, bladder injuries, and other digestive and kidney-related conditions.

The global market for ostomy drainage bags research report is further divided by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA) and Rest of the World.

  • Geographically, the Europe region dominated the market for ostomy drainage bags, followed by North America, partly due to Increasing pool of geriatric population, growing awareness about the available treatment options and favorable reimbursement policies in the region.
    • On the other hand, the Asia Pacific market expected to witness highest growth rate in the coming years, owing to increasing prevalence chronic conditions such as colorectal cancer, bladder cancer, and IBD in the region and growing awareness about various product options available in the market.

The global market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major competitors operating in the global ostomy drainage bags market and included in this report are Alcare Co., Ltd., B. Braun Melsungen AG, Coloplast A/S, ConvaTec, Inc., Flexicare Medical Limited, Hollister Inc., Pelcin Healthcare Ltd., Salts Healthcare Ltd., and Welland Medical Ltd.

  • Product
    • Colostomy Bags
    • Ileostomy Bags
    • Urostomy Bags
    • Continent Ileostomy Bags
    • Continent Urostomy Bags
  • Usage Type
    • Single-use Ostomy Drainage Bags
    • Multi-use Ostomy Drainage Bags
  • Clinical Application
    • Colorectal Cancer
    • Bladder Cancer
    • Colonic Diverticulitis
    • Inflammatory Bowel Disease
    • Other Diseases (Crohn’s Disease, Ulcerative Colitis)
  • Sales Channel
    • Hospitals
    • Community
  • Geography
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World
  • Company Profiles
    • Alcare Co. Ltd.
    • B. Braun Melsungen AG
    • Coloplast A/S
    • ConvaTec, Inc.
    • Hollister, Inc. (Dansac)
    • Pelcin Healthcare Ltd.
    • Salts Healthcare Ltd.
    • Welland Medical Ltd.

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/ostomy-drainage-bags-market/

Related publications:



    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]

    Subject*

    Message*

    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 463-5840
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: [email protected]